Bumrungrad Hospital Public Company Limited (BZ7A) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bumrungrad Hospital Public Company Limited (BZ7A) has a cash flow conversion efficiency ratio of 0.067x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.10 Billion ≈ $2.45 Billion USD) by net assets (€31.17 Billion ≈ $36.44 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Bumrungrad Hospital Public Company Limit fund operations to measure how many days the company can operate on defensive assets alone.
Bumrungrad Hospital Public Company Limited - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Bumrungrad Hospital Public Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Bumrungrad Hospital Public Company Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bumrungrad Hospital Public Company Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Alba Mineral Resources
LSE:ALBA
|
-0.053x |
|
Vox Valor Capital Ltd.
LSE:VOX
|
-0.001x |
|
Nanoco Group plc
LSE:NANO
|
-0.051x |
|
AIQ Ltd
LSE:AIQ
|
0.172x |
|
Contango Holdings PLC
LSE:CGO
|
-0.024x |
|
Sound Energy PLC
LSE:SOU
|
-0.069x |
|
Firering Strategic Minerals Plc
LSE:FRG
|
-0.123x |
|
Tiger Royalties and investments Plc
LSE:TIR
|
-0.272x |
Annual Cash Flow Conversion Efficiency for Bumrungrad Hospital Public Company Limited (2016–2025)
The table below shows the annual cash flow conversion efficiency of Bumrungrad Hospital Public Company Limited from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see Bumrungrad Hospital Public Company Limit market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €31.17 Billion ≈ $36.44 Billion |
€8.25 Billion ≈ $9.65 Billion |
0.265x | -15.11% |
| 2024-12-31 | €27.80 Billion ≈ $32.50 Billion |
€8.67 Billion ≈ $10.14 Billion |
0.312x | +2.39% |
| 2023-12-31 | €24.10 Billion ≈ $28.17 Billion |
€7.34 Billion ≈ $8.58 Billion |
0.305x | -1.91% |
| 2022-12-31 | €20.01 Billion ≈ $23.39 Billion |
€6.21 Billion ≈ $7.26 Billion |
0.311x | +53.85% |
| 2021-12-31 | €17.62 Billion ≈ $20.60 Billion |
€3.56 Billion ≈ $4.16 Billion |
0.202x | +68.20% |
| 2020-12-31 | €18.84 Billion ≈ $22.02 Billion |
€2.26 Billion ≈ $2.64 Billion |
0.120x | -50.34% |
| 2019-12-31 | €20.27 Billion ≈ $23.69 Billion |
€4.90 Billion ≈ $5.73 Billion |
0.242x | -4.31% |
| 2018-12-31 | €18.74 Billion ≈ $21.91 Billion |
€4.73 Billion ≈ $5.53 Billion |
0.253x | -19.54% |
| 2017-12-31 | €16.70 Billion ≈ $19.53 Billion |
€5.24 Billion ≈ $6.13 Billion |
0.314x | -10.28% |
| 2016-12-31 | €14.79 Billion ≈ $17.29 Billion |
€5.17 Billion ≈ $6.05 Billion |
0.350x | -- |
About Bumrungrad Hospital Public Company Limited
Bumrungrad Hospital Public Company Limited owns and operates hospitals and healthcare centers in Thailand and internationally. It offers services in the areas of allergy, arrhythmia, behavioural health, breast, home, heart valve, robotic surgery, rehabilitation, spine, pediatrics, colorectal surgery, complex coronary artery intervention, comprehensive sleep, cornea transplant, dental, diagnostic,… Read more